Clinical Trial Update: VEAPS: Vitamin E Atherosclerosis Prevention Study [Phase 2, Phase 3]

View source ↗

Summary

The VEAPS trial investigated Vitamin E (alpha-tocopherol) for atherosclerosis prevention in Phase 2/3 and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Vitamin E (tocopherol)

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Atherosclerosis | Phase 2, Phase 3 | Status: COMPLETED